Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
4.400
-0.050 (-1.12%)
At close: Dec 5, 2025, 4:00 PM EST
4.440
+0.040 (0.91%)
After-hours: Dec 5, 2025, 7:51 PM EST
Anavex Life Sciences Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Anavex Life Sciences stock have an average target of 22, with a low estimate of 20 and a high estimate of 24. The average target predicts an increase of 400.00% from the current stock price of 4.40.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Anavex Life Sciences stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +354.55% | Nov 28, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $24 | Strong Buy | Maintains | $24 | +445.45% | Nov 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $42 → $20 | Strong Buy | Maintains | $42 → $20 | +354.55% | Nov 19, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $46 → $24 | Strong Buy | Maintains | $46 → $24 | +445.45% | Nov 14, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $46 | Strong Buy | Maintains | $46 | +945.45% | Oct 29, 2025 |
Financial Forecast
Revenue This Year
263.84M
Revenue Next Year
133.95M
from 263.84M
Decreased by -49.23%
EPS This Year
-0.53
from -0.54
EPS Next Year
0.58
from -0.53
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 814.8M | 233.1M | |||
| Avg | 263.8M | 134.0M | |||
| Low | n/a | 39.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | -11.6% | |||
| Avg | - | -49.2% | |||
| Low | - | -84.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.51 | 1.33 | |||
| Avg | -0.53 | 0.58 | |||
| Low | -0.55 | -0.14 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.